October 17, 2017 Clinical Research/Diagn. Informatics & Software M&A, Partnerships

The Jackson Laboratory and Seven Bridges Collaborate to Build Centralized Data Platform to Advance Cancer Research

October 17, 2017 National Cancer Institute awards $2M grant to fund joint PDX data center to integrate, share, and analyze cancer treatment data for research community FARMINGTON, Conn., and BOSTON, Mass., October 17, 2017 – The Jackson Laboratory (JAX), a nonprofit biomedical research institution, and Seven Bridges, the leading biomedical data analysis company, today announced a new collaboration to... Read more

October 9, 2017 Clinical Research/Diagn. Informatics & Software Life Science Tools M&A, Partnerships

QIAGEN and CENTOGENE to collaborate in bioinformatics for genetic diseases

Aiding the analysis of hereditary disorders by integrating genomic and clinical databases Hilden and Rostock, Germany, and Germantown, Maryland, October 09, 2017 –QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and CENTOGENE AG today announced a collaboration and co-marketing agreement to provide customers more complete Sample to Insight research and clinical testing solutions in rare genetic diseases.... Read more

October 6, 2017 Clinical Research/Diagn.

Taking a significant leap forward in workflow support for ophthalmic surgery

The modular ophthalmology microscope platform Proveo 8 takes another significant step forward with further enhanced visualization and workflow support. The latest enhancements of the platform concern the core microscope and include brighter illumination for further optimized red reflex and automated adjustment of settings that respond to surgical visualization needs at every stage of anterior and... Read more

October 6, 2017 Clinical Research/Diagn. Lab Top-10 Liq. Handling & Robotics

Bruker Introduces Additional Key Products for Diagnosis and Susceptibility Testing of Invasive Fungal Diseases (IFD) into European Clinical Microbiology Markets

BELGRADE, Serbia, Oct. 6, 2017 /PRNewswire/ — At the Trends in Medical Mycology (www.timm2017.org) conference, Bruker today introduces the new, CE-IVD marked Fungiplex® Candida fast diagnostic assay, a multiplex real-time PCR test for the rapid identification of the most common pathogens associated with invasive candidiasis.  The new Fungiplex Candida assay does not require any culture steps,... Read more

October 6, 2017 Clinical Research/Diagn.

Augmented reality imaging supports clinical decision-making for vascular neurosurgeons

Wetzlar, Germany. At the Congress of Neurological Surgeons (CNS) Annual Meeting 2017, Boston, USA, Leica Microsystems will showcase its new groundbreaking GLOW augmented reality (AR) platform featuring the latest innovation in vascular fluorescence imaging: GLOW800 AR fluorescence. Visitors to the booth will also be able to experience FL560 fluorescence, the first FDA 510(k) cleared microscope... Read more

October 5, 2017 Clinical Research/Diagn. Product Launch

QIAGEN launches fourth-generation QuantiFERON®-TB Gold Plus in the U.S.

NovelCD4/CD8 design delivers most comprehensive evaluation of patients’ immune response to tuberculosis infection Germantown, Maryland, and Hilden, Germany, October 5, 2017 – QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. launch of QuantiFERON®-TB Gold Plus (QFT®-Plus), the fourth generation of its leading blood test for tuberculosis (TB) infection. QFT-Plus kits will be available... Read more

October 3, 2017 Clinical Research/Diagn. Product Launch

Roche launches NAVIFY Tumor Board solution to provide decision support to oncology care teams

Basel, 03 October 2017 Roche launches NAVIFY Tumor Board solution to provide decision support to oncology care teams The NAVIFY Tumor Board solution is a new, cloud-based software solution that fundamentally changes the way oncology care teams prepare for, conduct and document clinical treatment decisions for cancer patients It supports care team collaboration and standardizes... Read more

September 27, 2017 Clinical Research/Diagn. Licensing, IP, and Legal

Oxford Immunotec Announces Update in Patent Infringement Litigation

OXFORD, United Kingdom and MARLBOROUGH, Mass., September 27, 2017 (GLOBE NEWSWIRE) — Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced a decision of the U.S. District Court for the District of Massachusetts in the Company’s patent infringement... Read more

September 27, 2017 Bio/Pharma/CRO Clinical Research/Diagn.

First patient enrolled into phase I clinical trial of Oncolytic Virus HF10 against pancreatic cancer in Japan

First patient enrolled into phase I clinical trial of Oncolytic Virus HF10 against pancreatic cancer in Japan Kusatsu/Shiga, Japan — September 27, 2017 — Takara Bio Inc. (Takara Bio), today announced that the first patient with pancreatic cancer has been enrolled into Oncolytic Virus HF10(TBI-1401) phase I clinical trial in Japan on September　26, 2017. This... Read more

September 26, 2017 Clinical Research/Diagn. Product Launch

BD Expands Efforts to Combat Antimicrobial Resistance with New Diagnostic Test in Europe

FRANKLIN LAKES, N.J., Sept. 26, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch1 of the first automated phenotypic test to detect and classify carbapenemase-producing organisms (CPO). Available as part of the BD Phoenix™ automated microbiology system in Europe, the new BD Phoenix™ CPO detect test... Read more